Patterson Matthew R
Chief Executive Officer at Audentes Therapeutics, Inc.; Chief Operating Officer at FOLD
- Sold, on record
- $8.4M
- Dollars the filings state
- Form 4 sales
- 21
- Latest Nov 8, 2019
- Form 144 notices
- 0
- Proposed sales
- Companies
- 2
- Filed as an executive or holder
Companies
- Audentes Therapeutics, Inc.Chief Executive Officer
- FOLDAMICUS THERAPEUTICS, INC.Chief Operating Officer
Sales by reason
Form 4 sales per month, last 12 months.
Sales by company
- Audentes Therapeutics, Inc.231,426 shares
- FOLD40,000 shares
Shares sold, every Form 4 sale on record.
Timeline
- 1 Form 4 sale Audentes Therapeutics, Inc.UnusualApr 2, 2018 2018
Sold 700 shares at $30.01 ($21k)
Patterson Matthew R, President & CEO
Sold 100% of holdings ($21k position)0 shares left0x usual sizeFiling
- 2 Form 4 sale Audentes Therapeutics, Inc.UnusualMay 21, 2018 +49 days
Sold 20,300 shares at $38.15 ($774k)
Patterson Matthew R, President & CEO
Sold 100% of holdings ($774k position)0 shares left1.6x usual sizeFiling
- 3 Form 4 sale Audentes Therapeutics, Inc.UnusualJul 5, 2018 +45 days
Sold 71,048 shares at $39.55 ($2.8M)
Patterson Matthew R, Chief Executive Officer
Sold 100% of holdings ($2.8M position)0 shares left4.7x usual sizeFiling
- 4 Form 4 sale Audentes Therapeutics, Inc.UnusualSep 18, 2018 +75 days
Sold 12,952 shares at $40.00 ($518k)
Patterson Matthew R, Chief Executive Officer
Sold 100% of holdings ($518k position)0 shares left0.7x usual sizeFiling
- 5 Form 4 sale Audentes Therapeutics, Inc.UnusualOct 1, 2018 +13 days
Sold 21,000 shares at $38.16 ($801k)
Patterson Matthew R, Chief Executive Officer
Sold 58.3% of holdings ($1.4M position)15,000 shares left1.4x usual sizeFiling
- 6 Form 4 sale Audentes Therapeutics, Inc.Plan not statedFeb 25, 2019 +147 days
Sold 21,000 shares at $30.00 ($630k)
Patterson Matthew R, Chief Executive Officer
Sold 15% of holdings ($4.2M position)118,700 shares left1.2x usual sizeFiling
- 7 Form 4 sale Audentes Therapeutics, Inc.Plan not statedAug 12, 2019 +168 days
Sold 20,000 shares at $34.05 ($681k)
Patterson Matthew R, Chief Executive Officer
Sold 14.8% of holdings ($4.6M position)115,368 shares left1x usual sizeFiling
- 8 Form 4 sale Audentes Therapeutics, Inc.Plan not statedNov 8, 2019 +88 days
Sold 14,426 shares at $30.00 ($433k)
Patterson Matthew R, Chief Executive Officer
Sold 11.3% of holdings ($3.8M position)113,394 shares left0.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (21)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Nov 8, 2019 | Nov 12, 2019 | Audentes Therapeutics, Inc. | Chief Executive Officer | Form 4 sale | 14,426 | $433k | 11.3% | Plan not stated | SEC |
| Aug 12, 2019 | Aug 14, 2019 | Audentes Therapeutics, Inc. | Chief Executive Officer | Form 4 sale | 20,000 | $681k | 14.8% | Plan not stated | SEC |
| Feb 25, 2019 | Feb 27, 2019 | Audentes Therapeutics, Inc. | Chief Executive Officer | Form 4 sale | 21,000 | $630k | 15.0% | Plan not stated | SEC |
| Oct 1, 2018 | Oct 2, 2018 | Audentes Therapeutics, Inc. | Chief Executive Officer | Form 4 sale | 21,000 | $801k | 58.3% | Unusual | SEC |
| Sep 18, 2018 | Sep 20, 2018 | Audentes Therapeutics, Inc. | Chief Executive Officer | Form 4 sale | 12,952 | $518k | 100.0% | Unusual | SEC |
| Jul 5, 2018 | Jul 5, 2018 | Audentes Therapeutics, Inc. | Chief Executive Officer | Form 4 sale | 71,048 | $2.8M | 100.0% | Unusual | SEC |
| May 21, 2018 | May 23, 2018 | Audentes Therapeutics, Inc. | President & CEO | Form 4 sale | 20,300 | $774k | 100.0% | Unusual | SEC |
| Apr 2, 2018 | Apr 4, 2018 | Audentes Therapeutics, Inc. | President & CEO | Form 4 sale | 700 | $21k | 100.0% | Unusual | SEC |
| Oct 2, 2017 | Oct 4, 2017 | Audentes Therapeutics, Inc. | President & CEO | Form 4 sale | 25,000 | $698k | 100.0% | Unusual | SEC |
| Sep 18, 2017 | Sep 19, 2017 | Audentes Therapeutics, Inc. | President & CEO | Form 4 sale | 10,000 | $251k | 100.0% | Unusual | SEC |
| Jul 13, 2017 | Jul 14, 2017 | Audentes Therapeutics, Inc. | President & CEO | Form 4 sale | 15,000 | $300k | 7.4% | Plan not stated | SEC |
| Oct 31, 2008 | Nov 3, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 2,300 | $23k | 5.9% | Plan not stated | SEC |
| Oct 23, 2008 | Oct 24, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 3,200 | $33k | 7.6% | Plan not stated | SEC |
| Oct 21, 2008 | Oct 22, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 4,500 | $48k | 9.7% | Plan not stated | SEC |
| Aug 20, 2008 | Aug 21, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 2,000 | $27k | 4.1% | Plan not stated | SEC |
| Aug 19, 2008 | Aug 20, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 8,000 | $116k | 14.2% | Plan not stated | SEC |
| Jun 20, 2008 | Jun 24, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 1,400 | $16k | 2.3% | Plan not stated | SEC |
| Jun 19, 2008 | Jun 20, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 1,900 | $21k | 3.1% | Plan not stated | SEC |
| Jun 17, 2008 | Jun 18, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 6,700 | $75k | 10.1% | Plan not stated | SEC |
| Apr 16, 2008 | Apr 16, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 4,500 | $46k | 6.3% | Plan not stated | SEC |
| Apr 14, 2008 | Apr 16, 2008 | FOLD | Chief Operating Officer | Form 4 sale | 5,500 | $58k | 7.2% | Plan not stated | SEC |